SULFOBACIN-A;(2R,3R)-3-HYDROXY-2-[(R)-3-HYDROXY-15-METHYLHEXADECANAMIDO]-15-METHYLHEXADECANE-SULFONIC-ACID
Compound with spectra: 1 NMR
![SULFOBACIN-A;(2R,3R)-3-HYDROXY-2-[(R)-3-HYDROXY-15-METHYLHEXADECANAMIDO]-15-METHYLHEXADECANE-SULFONIC-ACID](/api/compound/8q0R7bla2Uk.png?ph=true&h=300&w=458 "SULFOBACIN-A;(2R,3R)-3-HYDROXY-2-[(R)-3-HYDROXY-15-METHYLHEXADECANAMIDO]-15-METHYLHEXADECANE-SULFONIC-ACID")
| SpectraBase Compound ID | 8q0R7bla2Uk |
|---|---|
| InChI | InChI=1S/C34H69NO6S/c1-29(2)23-19-15-11-7-5-9-13-17-21-25-31(36)27-34(38)35-32(28-42(39,40)41)33(37)26-22-18-14-10-6-8-12-16-20-24-30(3)4/h29-33,36-37H,5-28H2,1-4H3,(H,35,38)(H,39,40,41)/t31-,32-,33-/m0/s1 |
| InChIKey | IENDTBZONILTAG-ZDCRTTOTSA-N |
| Mol Weight | 620.0 g/mol |
| Molecular Formula | C34H69NO6S |
| Exact Mass | 619.48456 g/mol |
| Enantiomer InChIKey | IENDTBZONILTAG-WRVRXEDSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
2'-O-(Methoxymethyl)symbiramide
GRACILAMIDE_B
Gracilamide B
LMCER-2-1;(2S,3S,4R,2'R)-2-(2-HYDROXYHEXADECANOYLAMINO)-16-METHYL-4-OCTADECANE-1,3,4-TRIOL
LMCER-2-7;(2S,3S,4R,2'R)-2-(2-HYDROXYDOCOSANOYLAMINO)-14-METHYL-HEXADECANE-1,3,4-TRIOL
2-N-Pentacosanoyl-4,5-dihydroxy-4,5-dihydrosphingosine
NEWBOULDIAMIDE
GLUMOAMIDE;(2R,7E)-2-HYDROXY-N-[(2S,3S,4R)-1,3,4-TRIHYDROXY-HEXADECAN-2-YL]-HEXACOS-7-ENAMIDE
(2S,3S,4R,9Z)-2-[(2R)-2-HYDROXYTRICOSANOYLAMINO]-9-OCTADECENE-1,3,4-TRIOL
PORTULACERAMIDE-A;(2S,3S,4R,8E)-2-[(2'R)-2-HYDROXYLPENTADECANOYLAMINO]-8-DODECENE-1,3,4-TRIOL
| Title | Journal or Book | Year |
|---|---|---|
| Sulfobacins A and B, Novel von Willebrand Factor Receptor Antagonists. II. Structural Elucidaffon. | The Journal of Antibiotics | 1995 |